ロード中...
Inhibition of XIAP increases carboplatin sensitivity in ovarian cancer
PURPOSE: Carboplatin is a first-line treatment for ovarian cancer. However, most patients develop resistance and undergo disease recurrence. This study aims to explore the relationship between the expression of X-linked inhibitor of apoptosis protein (XIAP) and carboplatin sensitivity in ovarian can...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6287417/ https://ncbi.nlm.nih.gov/pubmed/30584333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S171053 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|